期刊文献+

内蒙古汉族儿童白血病与HLA—DRB1多态性的关联分析

Study on the Association between Leukemia in Children of Han People in Inner Mongolia and Polymorphism of HLA-DRBI Alleles
下载PDF
导出
摘要 目的通过对内蒙古地区汉族白血病患儿HLA-DRB1基因多态性的分析,以期寻找白血病的易感基因,有助于进一步了解白血病的相关发病机制。方法采用PCR-SSP(序列特异引物聚合酶链反应)方法,对病例组及健康对照组进行HLA-DRB1基因的分型。采用四格表卡方检验,经SPSS13.0统计软件进行统计学分析。结果病例组HLA-DRB1*09的基因频率与对照组的基因频率差异有统计学意义(P<0.05);病例组中HLA-DRB1*14的基因频率与对照组的基因频率差异具有统计学意义(P<0.05);病例组中HLA-DRB1*07的基因频率与对照组的基因频率差异具有统计学意义(P<0.05)。结论 HLA-DRB1*09和HLA-DRB1*14可能是内蒙古汉族儿童白血病的遗传易感基因型,HLA-DRB1*07可能是内蒙古汉族儿童白血病的遗传拮抗基因型。 Objective we analyse HLA-DRB1 allele polymorphism of leukemia in children of Han people residing in Inner Mongolia in order to determine the susceptible genetic factors of leukemia,which would be useful to study at the relative mechanism of leukemia.Methods The method of DNA amplification with polymerase chain reaction-sequence-specific primers(PCR-SSP) was used to determine alleles of HLA-DRB1 in experimental group and the control group.Utilizingχ~2 test to analyse the collected data in SPSS 13.0 software in the statistic analysis.Results The gene frequency of HLA- DRB1*09 in experimental group and in the control group are statistical significance.P0.05.The gene frequency of HLA- DRB1*14 in experimental group and in the control group are significant difference.P0.05.The gene frequency of HLA- DRB1*07 in experimental group and in the control group are statistical significance(P0.05).Conclusions There maybe the genetic susceptibility effect of HLA-DRB1*09 allele and HLA- DRB1*14 allele in Inner Mongolia Han population on childhood leukemia.While,there maybe the genetic resistance effect of HLA- DRB 1*07 allele.
作者 侯慧 刘建平
出处 《疾病监测与控制》 2011年第9期525-526,共2页 Journal of Diseases Monitor and Control
关键词 HLA-DRB1基因 白血病 基因多态性 HLA-DRB1 gene Leukemia Polymorphism
  • 相关文献

参考文献9

  • 1Hjalggrim LL,Rostgaard K,Schmiegelow K,et al.Age-and sex-specific incidence of childhood leukemia by immunophenotype in the nordic countries[J].J Natl Cancer lnst,2003,95(20): 1539-1544.
  • 2Ward M M,Barbaro N M,Laxer K D,et al.Preoperative valproate administration dose not increase blood loss during temporal lobectomy [J].Epilepsia, 1996,37(2):98-102.
  • 3Marsh SG, Albert ED,Bodmer WF, et al.Nnomenclature for factors of the HLA system[J].Immunol Today,2002,60(6):407-464.
  • 4Nepom GT, Erlich H.MHC class II molecules and autoimmunity[J].Ann Rev Immunol, 1991,9(5):493 -525.
  • 5Florence R, Depontieua,Jie Qianb,et al.ldentification of tumor-associated. MHC class II -restricted phosphopeptides as targets for immunotherapy [J].PNAS,2002,106(29): 12073-12078.
  • 6周丹,邹红岩,金士正,李桢,孙革.南方汉族人群白血病患者与HLA基因相关性的研究[J].江西医学检验,2005,23(4):316-319. 被引量:7
  • 7金静君,苏东辉,陈志哲,胡洁,薛士杰,何萍.福建汉族慢性粒细胞性白血病患者HLA-DRB1基因分析[J].福建医科大学学报,2004,38(4):401-403. 被引量:2
  • 8戴云鹏,阎文英,沈柏均,杨超,谢松梅,朱娜,王新党.儿童急性淋巴细胞白血病患者HLA-A,B,DRB1等位基因多态性研究[J].中国优生与遗传杂志,2003,11(1):25-29. 被引量:16
  • 9Olerup O,Zetterquist H.HLA-DR typing by PCR amplification with sequence specific primers(PCR 2SSP)in 2 hours:An alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transp-Lantations[J].Tissue Antigens,1992,39(5): 225-235.

二级参考文献16

  • 1侯虞华 钟伟民 等.慢性粒细胞白血病和HLA[J].中华内科杂志,1988,27:33-35.
  • 2Bortin MM. AmaroJ, Bach FH, et al. HLA association with Leukemia[J]. Blood, 1987,70:227.
  • 3Bateman. A C Howell. Human Leukocyte antigens and cancer:is it our genes[J]. J.Pathol, 1999,(188):231.
  • 4Jawahar L, Tiwavi and Paul I. Terasaki, HLA and Disease Associations 1985 By Sringer-Verlag[J]. New York, Inc,278 ~ 31.
  • 5陈灏珠.实用内科学[M].北京:人民卫生出版社,1997.858.
  • 6艾辉胜.白血病的现代诊断与分型[A].见:艾辉生 罗荣城 乐晓峰主编.现代白血病学[C].北京:人民军医出版社,1997.133—135.
  • 7Jahagirdar BN,Miller JS,Shet A,et al. Novel therapies for chronic myelgenous leukemia [J]. Exp Hematol, 2001,29(5):543-546.
  • 8Cortes J,Fayad L,Kantarjian H,et al. Association of HLA phenotype and response to interferon-α in patients with chronic myelogenous leukemia[J]. Leukemia, 1998, 12 (4): 455-462.
  • 9Bosch GJ,Joosten AM,Kessler JH,et al. Recognition of BCRABL positive leukemic blasts by human CD4+ T cells elicited by primary in vitro immunization with a BCR-ABL breakpoint peptide[J]. Blood, 1996,88(11):3522-3527.
  • 10Yasukawa M,Ohminami H,Kaneko S,et al. CD4+cytotoxic Tcell clones specific for bcr-abl b3a2 fusion peptide augment colony formation by chronic myelogenous leukemia cells in a b3a2-specific and HLA-DR restricted manner [Jl. Blood,1998,92(11) :3355-3361.

共引文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部